How Health System Specialty Pharmacies Will Help Payers Succeed in a Value-Based, Data-Driven Futurehttps://shieldshealthsolutions.com/content/uploads/2021/06/shields-blog-icon-case-whitepaper.svg204115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This white paper highlights the importance of collaboration between payers and health systems and the benefits of carving in specialty pharmacy access at the point of care. These partnerships are…
How Health Systems Can Optimize Revenue Streams and Improve the Patient Experience by Providing Home Infusion Pharmacy Serviceshttps://shieldshealthsolutions.com/content/uploads/2021/06/shields-blog-icon-case-whitepaper.svg204115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This white paper describes the home infusion opportunity, outlines factors to consider in deciding whether to launch a home infusion program, and recommends resources. A case study describing an Excelera Home Infusion Solutions engagement is included.
• Home infusion is a growing category.
• Many health systems find that home infusion aligns with clinical and financial goals.
• A consultant can help health systems get to market faster as they develop their in-house home infusion expertise.
Shields Health Solutions Receives Equity Investments From Welsh, Carson, Anderson & Stowe and Walgreen Co.https://shieldshealthsolutions.com/content/uploads/2019/07/download-1.png288175Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
STOUGHTON, Mass. & NEW YORK & DEERFIELD, Ill.–(BUSINESS WIRE)–Shields Health Solutions, Welsh, Carson, Anderson & Stowe (“WCAS”) and Walgreen Co. (“Walgreens”) today announced the parties have entered into a definitive…